Zevra Therapeutics マネジメント
マネジメント 基準チェック /04
現在、CEO に関する十分な情報がありません。
主要情報
Neil McFarlane
最高経営責任者
US$3.4m
報酬総額
| CEO給与比率 | 4.6% |
| CEO在任期間 | 1.1yrs |
| CEOの所有権 | n/a |
| 経営陣の平均在職期間 | 1.8yrs |
| 取締役会の平均在任期間 | 1.6yrs |
経営陣の近況
Recent updates
Here's What Analysts Are Forecasting For Zevra Therapeutics, Inc. (NASDAQ:ZVRA) After Its Third-Quarter Results
Nov 15
Investors Appear Satisfied With Zevra Therapeutics, Inc.'s (NASDAQ:ZVRA) Prospects As Shares Rocket 34%
Aug 30Zevra Therapeutics, Inc.'s (NASDAQ:ZVRA) 26% Jump Shows Its Popularity With Investors
Jul 12Analysts Just Shaved Their Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Forecasts Dramatically
Apr 07Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Just Reported And Analysts Have Been Cutting Their Estimates
Apr 04Zevra Therapeutics, Inc.'s (NASDAQ:ZVRA) Stock Retreats 27% But Revenues Haven't Escaped The Attention Of Investors
Apr 02Investors Appear Satisfied With Zevra Therapeutics, Inc.'s (NASDAQ:ZVRA) Prospects
Dec 28Bullish: Analysts Just Made A Noticeable Upgrade To Their Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Forecasts
Sep 05This Just In: Analysts Are Boosting Their Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Outlook for This Year
Aug 20Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Stocks Shoot Up 31% But Its P/S Still Looks Reasonable
Apr 17US$18.00: That's What Analysts Think Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Is Worth After Its Latest Results
Mar 10Is Zevra Therapeutics (NASDAQ:ZVRA) Using Debt In A Risky Way?
Mar 08Bearish: Analysts Just Cut Their KemPharm, Inc. (NASDAQ:KMPH) Revenue and EPS estimates
Nov 16Does KemPharm (NASDAQ:KMPH) Have A Healthy Balance Sheet?
Nov 11KemPharm posts Phase 1 data to support further studies for sleep disorder therapy
Sep 28KemPharm wins Buy rating at Canaccord on CNS focus
Sep 15CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$90m |
| Jun 30 2024 | n/a | n/a | -US$67m |
| Mar 31 2024 | n/a | n/a | -US$49m |
| Dec 31 2023 | US$3m | US$158k | -US$46m |
報酬と市場: Neilの 総報酬 ($USD 3.45M ) は、 US市場 ($USD 2.18M ) の同規模の企業の平均を上回っています。
報酬と収益: Neilの報酬と会社の業績を比較するにはデータが不十分です。
CEO（最高経営責任者
Neil McFarlane (51 yo)
1.1yrs
在職期間
US$3,445,231
報酬
Mr. Neil F. McFarlane serves as President & Chief Executive Officer at Zevra Therapeutics, Inc. since October 10, 2023 and serves as its Director since October 9, 2023. He served as Independent Director at...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 1.1yrs | US$3.45m | データなし | |
| Co-Founder & Chief Development Officer | no data | US$1.67m | 0.051% $ 248.5k | |
| CFO, Secretary & Treasurer | 9.4yrs | US$2.26m | 0.035% $ 168.6k | |
| Chief Commercial Officer & Executive VP of Business Development | 1.8yrs | US$1.82m | 0.0066% $ 32.0k | |
| Chief Scientific Officer | 1.8yrs | US$1.08m | 0.0051% $ 25.0k | |
| Vice President of Investor Relations & Corporate Communications | 2.3yrs | データなし | データなし | |
| Chief Legal Officer | less than a year | データなし | データなし | |
| Chief People Officer | less than a year | データなし | データなし | |
| Senior Vice President of Manufacturing | 1.8yrs | データなし | データなし | |
| Senior Vice President of Clinical Development | 1.8yrs | データなし | データなし | |
| Senior Vice President of Medical Affairs & Advocacy | 1.8yrs | データなし | データなし | |
| Chief Medical Officer | less than a year | データなし | データなし |
1.8yrs
平均在職期間
52yo
平均年齢
経験豊富な経営陣: ZVRAの経営陣は 経験豊富 とはみなされません ( 1.8年の平均在職年数)。これは新しいチームを示唆しています。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 1.1yrs | US$3.45m | データなし | |
| Independent Director | 1.6yrs | US$274.00k | 0% $ 0 | |
| Independent Director | 1.6yrs | US$258.02k | 0% $ 0 | |
| Independent Chair | 3.3yrs | US$324.39k | 0.0014% $ 6.6k | |
| Member of Scientific and Medical Advisory Board | no data | データなし | データなし | |
| Independent Director | 1.6yrs | US$264.31k | 0.056% $ 273.9k | |
| Independent Director | 1.6yrs | US$260.67k | 0.0028% $ 13.7k | |
| Chairman of Scientific and Medical Advisory Board | 17.8yrs | データなし | データなし | |
| Member of Scientific & Medical Advisory Board | no data | データなし | データなし | |
| Co-Chair of Physician Advisory Council | 11.1yrs | データなし | データなし | |
| Co-Chair of Physician Advisory Council | 11.1yrs | データなし | データなし | |
| Independent Director | 1.3yrs | US$243.04k | 0.037% $ 182.6k |
1.6yrs
平均在職期間
58yo
平均年齢
経験豊富なボード: ZVRAの 取締役会 は 経験豊富 ではない ( 1.6年の平均在任期間) ため、新しい取締役会が必要であると考えられます。